The role of immunosuppression and immune-activation in classic Kaposi's sarcoma

被引:0
|
作者
Touloumi, G
Hatzakis, A
Potouridov, I
Milona, I
Strarigos, J
Katsambas, A
Giraldo, G
Beth-Giraldo, E
Biggar, RJ
Mueller, N
Trichopoulos, D
机构
[1] Athens Med Sch, Dept Hyg & Epidemiol, GR-11527 Athens, Greece
[2] Univ Athens Clin, Dept Dermatol & Venerol, Andreas Syngros Hosp, Athens, Greece
[3] Inst Nazl Tumri Fond G Pascale, Dept Expt Oncol, Naples, Italy
[4] Inst Nazl Tumri Fond G Pascale, AIDS Reference Ctr, Naples, Italy
[5] NCI, Viral Epidemiol Branch, Bethesda, MD USA
[6] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
D O I
10.1002/(SICI)1097-0215(19990909)82:6<817::AID-IJC8>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T-cell subsets, as well as neopterin and beta(2)-microglobulin in 91 HIV-negative Greek patients with histologically confirmed CKS and in 107 controls matched for age and sex. CKS cases had slightly lower leukocyte counts (p = 0.08) and lymphocyte counts (p = 0.02). Although the percentage of CD4 and CD8 T-lymphocytes were not significantly different from controls (p = 0.10 and p = 0.45, respectively), CD4 T-lymphocytes were lower in cases than controls (812 cells/mu L and 1,009 cells/mu L, respectively; p = 0.01); part of this difference resulted from the lower lymphocyte counts (p 0.07 after adjusting for lymphocyte counts). However, neopterin and Pz-microglobulin were both considerably elevated [geometric mean (95% CI): 8.35 (7.27-9.73) nmol/L and 2,904 (2,479-3,401) mu g/L in cases and 5.86 (5.40-6.35) nmol/lL and 2,042 (1,880-2,218) mu g/L in controls, respectively]. We conclude that CKS patients are predominantly characterised by immune activation, although an element of minor immunosuppression may also be present. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:817 / 821
页数:5
相关论文
共 50 条
  • [31] Is volcanic soil a cofactor for classic Kaposi's sarcoma?
    Montella, M
    Serraino, D
    Crispo, A
    Rezza, G
    Carbone, S
    Tamburini, M
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (12) : 1185 - 1186
  • [32] Classic Kaposi's sarcoma on lymphedema secondary to catheterization
    Barco, D.
    Alegre, M.
    Alomar, A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2008, 99 (08): : 665 - 667
  • [33] Classic Kaposi's sarcoma in Italy, 1985–1998
    L Dal Maso
    J Polesel
    V Ascoli
    P Zambon
    M Budroni
    S Ferretti
    R Tumino
    G Tagliabue
    S Patriarca
    M Federico
    M Vercelli
    A Giacomin
    G Vicario
    F Bellù
    F Falcini
    E Crocetti
    V De Lisi
    S Vitarelli
    S Piffer
    F Stracci
    D Serraino
    G Rezza
    S Franceschi
    British Journal of Cancer, 2005, 92 : 188 - 193
  • [34] Treatment of Classic Kaposi's Sarcoma with Topical Imiquimod
    Goiriz, Rebeca
    Rios-Buceta, Luis
    Gonzalez de Arriba, Ana
    Araguees, Maximiliano
    Garcia-Diez, Amaro
    DERMATOLOGIC SURGERY, 2009, 35 (01) : 147 - 149
  • [35] Classic Kaposi's sarcoma in southern Sardinia, Italy
    Atzori, L
    Fadda, D
    Ferreli, C
    Pastorelli, C
    Iannelli, P
    Rais, M
    Faa, G
    Cocco, P
    Aste, N
    BRITISH JOURNAL OF CANCER, 2004, 91 (07) : 1261 - 1262
  • [36] Classic Kaposi's sarcoma as a first primary neoplasm
    Iscovich, J
    Boffetta, P
    Brennan, P
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (02) : 173 - 177
  • [37] Classic Kaposi's sarcoma: A review of 156 cases
    Cetin, Bulent
    Aktas, Bilge
    Bal, Oznur
    Algin, Efnan
    Akman, Tulay
    Koral, Lokman
    Kaplan, Mehmet Ali
    Demirci, Umut
    Uncu, Dogan
    Ozet, Ahmet
    DERMATOLOGICA SINICA, 2018, 36 (04) : 185 - 189
  • [38] Gemcitabine in classic Kaposi's sarcoma: A pilot study
    Badalamenti, G.
    Incorvaia, L.
    Bonasera, A.
    Algeri, L.
    Dimino, A.
    Cucinella, A.
    Madonia, G.
    Scalia, R.
    Fanale, D.
    Li Pomi, F.
    Galvano, A.
    Gristina, V.
    Corsini, L. R.
    Brando, C.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1122 - S1122
  • [39] Classic Kaposi's sarcoma treated with topical rapamycin
    Diaz-Ley, Blanca
    Grillo, Emiliano
    Rios-Buceta, Luis
    Paoli, John
    Moreno, Carmen
    Vano-Galvan, Sergio
    Jaen-Olasolo, Pedro
    DERMATOLOGIC THERAPY, 2015, 28 (01) : 40 - 43
  • [40] Classic Kaposi's sarcoma as a second primary neoplasm
    Iscovich, J
    Boffetta, P
    Winkelmann, R
    Brennan, P
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (02) : 178 - 182